peg-300
poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, (300 mol EO average molar ratio)
 
Notes:
a tasteless laxative composed of peg3350; miralax is tradename. polymers of ethylene oxide and water and their ethers. they vary in consistency from liquid to solid, depending on the molecular weight, indicated by a number following the name. they are used as surfactants, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. some specific groups are lauromagrogols, nonoxynols, octoxynols and poloxamers.
Synonyms   Articles   Notes   Search
CAS Number: 25322-68-3Picture of molecule3D/inchi
Category: information only not used for fragrances or flavors
 
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar: Search
Google Books: Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents: Search
US Patents: Search
EU Patents: Search
PubMed: Search
NCBI: Search
Synonyms   Articles   Notes   Search   Top
Physical Properties:
Assay: 95.00 to 100.00 % 
Food Chemicals Codex Listed: No
Soluble in:
 water, 1e+006 mg/L @ 25 °C (est)
Synonyms   Articles   Notes   Search   Top
Organoleptic Properties:
 
Odor and/or flavor descriptions from others (if found).
 
 
Synonyms   Articles   Notes   Search   Top
Cosmetic Information:
None found
Synonyms   Articles   Notes   Search   Top
Suppliers:
Graham Chemical
PEG 300
Synonyms   Articles   Notes   Search   Top
Safety Information:
 
Hazards identification
 
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
 
Pictogram
 
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
intravenous-dog LDLo  3000 mg/kg
Journal of Pharmacology and Experimental Therapeutics. Vol. 103, Pg. 293, 1951.

oral-guinea pig LD50  15700 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-guinea pig LD50  17000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-guinea pig LD50  19600 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-guinea pig LD50  22500 mg/kg
Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 349, 1950.

oral-guinea pig LD50  28000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-guinea pig LD50  28900 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-guinea pig LD50  50000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-guinea pig LD50  50900 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-mouse LD50  473 mg/kg
Yaoxue Tongbao. Bulletin of Pharmacology. Vol. 21, Pg. 387, 1986.

intraperitoneal-mouse LD50  2000 mg/kg
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Journal of Pharmacology and Experimental Therapeutics. Vol. 103, Pg. 293, 1951.

intraperitoneal-mouse LD50  7500 mg/kg
National Technical Information Service. Vol. AD628-313

intraperitoneal-mouse LD50  8000 mg/kg
LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION
Journal of Pharmacology and Experimental Therapeutics. Vol. 103, Pg. 293, 1951.

intravenous-mouse LD50  7900 ug/kg
Research Progress in Organic-Biological and Medicinal Chemistry. Vol. 2, Pg. 316, 1970.

intravenous-mouse LD50  8550 mg/kg
Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 1581, 1976.

intravenous-mouse LD50  16000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-mouse LD50  28915 mg/kg
Proceedings of the European Society of Toxicology. Vol. 17, Pg. 351, 1976.

oral-mouse LD50  31000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-mouse LD50  34000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-mouse LD50  36000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

intravenous-rabbit LD50  8000 mg/kg
BLOOD: CHANGE IN CLOTTING FACTORS
Kriobiologiya i Kriomeditsina. Cryobiology and Cryomedicine. Vol. 4, Pg. 71, 1978.

oral-rabbit LD50  14000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-rabbit LD50  17300 mg/kg
International Journal of Toxicology. Vol. 18(Suppl

oral-rabbit LD50  17300 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rabbit LD50  19000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-rabbit LD50  26800 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rabbit LD50  28900 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rabbit LD50  76000 mg/kg
International Journal of Toxicology. Vol. 18(Suppl

oral-rabbit LD50  76000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD  > 4000 mg/kg
Union Carbide Data Sheet. Vol. 9/25/1969

intraperitoneal-rat LD50  6790 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50  9000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50  9700 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3849, 1982.

intraperitoneal-rat LD50  9708 mg/kg
Proceedings of the European Society of Toxicology. Vol. 17, Pg. 351, 1976.

intraperitoneal-rat LD50  12600 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50  14100 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3849, 1982.

intraperitoneal-rat LD50  15390 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50  15570 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50  16000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intraperitoneal-rat LD50  17000 mg/kg
Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 349, 1950.

intraperitoneal-rat LD50  17700 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

intravenous-rat LD50  7130 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3849, 1982.

intravenous-rat LD50  7312 mg/kg
Arzneimittel-Forschung. Drug Research. Vol. 26, Pg. 1581, 1976.

intravenous-rat LD50  7500 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3849, 1982.

intravenous-rat LD50  13000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50  600 mg/kg
Dow Chemical Company Reports. Vol. MSD-94

oral-rat LD50  1054 mg/kg
Dow Chemical Company Reports. Vol. MSD-95

oral-rat LD50  > 4000 mg/kg
Dow Chemical Company Reports. Vol. MSD-938

oral-rat LD50  22000 mg/kg
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 747, 1969.

oral-rat LD50  27500 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50  28000 mg/kg
Dow Chemical Company Reports. Vol. MSD-1112

oral-rat LD50  30000 mg/kg
Dow Chemical Company Reports. Vol. MSD-2203

oral-rat LD50  30200 mg/kg
Journal of the American Pharmaceutical Association, Scientific Edition. Vol. 39, Pg. 349, 1950.

oral-rat LD50  31600 mg/kg
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 747, 1969.

oral-rat LD50  31640 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50  32000 mg/kg
Dow Chemical Company Reports. Vol. MSD-937

oral-rat LD50  44200 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50  45000 mg/kg
"Patty's Industrial Hygiene and Toxicology," 3rd rev. ed., Clayton, G.D., and F.E. Clayton, eds., New York, John Wiley & Sons, Inc., 1978-82. Vol. 3 originally pub. in 1979; pub. as 2n rev. ed. in 1985.Vol. 2C, Pg. 3847, 1982.

oral-rat LD50  50000 mg/kg
"Toxicology of Drugs and Chemicals," Deichmann, W.B., New York, Academic Press, Inc., 1969Vol. -, Pg. 747, 1969.

oral-rat LD50  > 50000 mg/kg
Dow Chemical Company Reports. Vol. MSD-935

oral-rat LD50  > 50000 mg/kg
Dow Chemical Company Reports. Vol. MSD-940

oral-rat LD50  50000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50  51200 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

oral-rat LD50  51310 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

unreported-rat LD50  7800 mg/kg
United States Patent Document. Vol. #4767763

intravenous-rat LDLo  3 mg/kg
Toxicology and Applied Pharmacology. Vol. 16, Pg. 442, 1970.

intravenous-rat LDLo  22000 mg/kg
KIDNEY, URETER, AND BLADDER: HEMATURIA VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION)
Arzneimittel-Forschung. Drug Research. Vol. 23, Pg. 1087, 1973.

Dermal Toxicity:
subcutaneous-mouse LD50 18000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

skin-rabbit LD > 1000 mg/kg
Union Carbide Data Sheet. Vol. 9/25/1969

skin-rabbit LD50 > 20 mL/kg
International Journal of Toxicology. Vol. 18(Suppl

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-1112

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-2202

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-96

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-2203

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-937

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-939

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-935

skin-rabbit LD50 > 20000 mg/kg
Dow Chemical Company Reports. Vol. MSD-940

subcutaneous-rat LD50 16000 mg/kg
KIDNEY, URETER, AND BLADDER: OTHER CHANGES
Arzneimittel-Forschung. Drug Research. Vol. 3, Pg. 451, 1953.

Inhalation Toxicity:
Not determined
Synonyms   Articles   Notes   Search   Top
Safety in Use Information:
Category: information only not used for fragrances or flavors
Recommendation for peg-300 usage levels up to:
 not for fragrance use.
 
Recommendation for peg-300 flavor usage levels up to:
 not for flavor use.
Synonyms   Articles   Notes   Search   Top
Safety References:
EPI System: View
ClinicalTrials.gov: search
Daily Med: search
NIOSH International Chemical Safety Cards: search
Chemical Carcinogenesis Research Information System: Search
AIDS Citations: Search
Cancer Citations: Search
Toxicology Citations: Search
EPA GENetic TOXicology: Search
EPA Substance Registry Services (TSCA): 25322-68-3
EPA ACToR: Toxicology Data
EPA Substance Registry Services (SRS): Registry
National Institute of Allergy and Infectious Diseases: Data
WGK Germany: 1
Chemidplus: 0025322683
Synonyms   Articles   Notes   Search   Top
References:
Canada Domestic Sub. List: 25322-68-3
Pubchem (sid): 134996364
Synonyms   Articles   Notes   Search   Top
Other Information:
(IUPAC): Atomic Weights of the Elements 2011 (pdf)
Videos: The Periodic Table of Videos
tgsc: Atomic Weights use for this web site
(IUPAC): Periodic Table of the Elements
HMDB (The Human Metabolome Database): Search
MedlinePlusSupp: View
Wikipedia: View
Synonyms   Articles   Notes   Search   Top
Potential Blenders and core components note
 
None Found
 
Synonyms   Articles   Notes   Search   Top
Potential Uses:
None Found
Synonyms   Articles   Notes   Search   Top
Occurrence (nature, food, other): note
 not found in nature
Synonyms   Articles   Notes   Search   Top
Synonyms:
 poly(oxy-1,2-ethanediyl), .alpha.-hydro-.omega.-hydroxy-, (300 mol EO average molar ratio)
 polyethylene glycol (300)
 polyoxyethylene (300)
Synonyms   Articles   Notes   Search   Top
Articles:
PubMed: Adverse eff ects of polymeric nanoparticle poly(ethylene glycol)- block-polylactide methyl ether (PEG-b-PLA) on steroid hormone secretion by porcine granulosa cells.
PubMed: Effects of plasticizers on the physicochemical properties of kappa-carrageenan films extracted from Eucheuma cottonii.
PubMed: Green-Emitting Gd3Ga5O12: Tb(3+) Nanoparticles Phosphor: Synthesis, Structure, and Luminescence.
PubMed: Physicochemical and tribophysical properties of trioctylalkylammonium bis(salicylato)borate (N888n-BScB) ionic liquids: effect of alkyl chain length.
PubMed: Impact of additives on the formation of protein aggregates and viscosity in concentrated protein solutions.
PubMed: Time-to-response toxicity analysis as a method for drug susceptibility assessment in salmon lice.
PubMed: Biosynthesis of poly(3-hydroxybutyrate) copolymers by Azotobacter chroococcum 7B: A precursor feeding strategy.
PubMed: Effect of coating thickness of iron oxide nanoparticles on their relaxivity in the MRI.
PubMed: Stereolithographic (SLA) 3D printing of oral modified-release dosage forms.
PubMed: GC-elements controlling HRAS transcription form i-motif structures unfolded by heterogeneous ribonucleoprotein particle A1.
PubMed: CO2 Fixation into Novel CO2 Storage Materials Composed of 1,2-Ethanediamine and Ethylene Glycol Derivatives.
PubMed: Polyethylene Oxide (PEO) and Polyethylene Glycol (PEG) Polymer Sieving Matrix for RNA Capillary Electrophoresis.
PubMed: Progressive multifocal leukoencephalopathy in common variable immunodeficiency: mitigated course under mirtazapine and mefloquine.
PubMed: Preparation of poly(3-hydroxybutyrate-co-hydroxyvalerate) films from halophilic archaea and their potential use in drug delivery.
PubMed: [Validation study on a multi-residue analysis of pesticides in agricultural products by using phosphoric acid treatment and GC-MS/MS].
PubMed: Reactive uptake of an isoprene-derived epoxydiol to submicron aerosol particles.
PubMed: Fluorescence spectroscopy of individual semiconductor nanoparticles in different ethylene glycols.
PubMed: Epigenetic modification, dehydration, and molecular crowding effects on the thermodynamics of i-motif structure formation from C-rich DNA.
PubMed: Influence of suspension stabilisers on the delivery of protein-loaded porous poly (DL-lactide-co-glycolide) (PLGA) microparticles via pressurised metered dose inhaler (pMDI).
PubMed: Influence of additives to the formulation of n.c.a. [¹¹C]PiB on sterile filter performance.
PubMed: Synthesis of chromeno[3,4-B]quinoline derivatives by heterogeneous [Cu(II)BHPPDAH] catalyst without being immobilized on any support under mild conditions using PEG 300 as green solvent.
PubMed: Cell attachment on poly(3-hydroxybutyrate)-poly(ethylene glycol) copolymer produced by Azotobacter chroococcum 7B.
PubMed: Atomic resolution structures of the c-Src SH3 domain in complex with two high-affinity peptides from classes I and II.
PubMed: The terpolymer produced by Azotobacter chroococcum 7B: effect of surface properties on cell attachment.
PubMed: Oral insulin delivery in rats by nanoparticles prepared with non-toxic solvents.
PubMed: Mutation and crystallization of the first KH domain of human polycytosine-binding protein 1 (PCBP1) in complex with DNA.
PubMed: Enhancement of griseofulvin release from liquisolid compacts.
PubMed: Trafficking of drug candidates relevant for sports drug testing: detection of non-approved therapeutics categorized as anabolic and gene doping agents in products distributed via the Internet.
PubMed: ATP hydrolysis-dependent asymmetry of the conformation of CFTR channel pore.
PubMed: The effect of polyoxyethylene polymers on the transport of ranitidine in Caco-2 cell monolayers.
PubMed: Designing of mouse model: a new approach for studying sulphur mustard-induced skin lesions.
PubMed: Comparative effects of alcohols (methanol, glycerol) and polyethylene glycol (PEG-300) on acid denatured state of goat liver cystatin.
PubMed: Electrochemical characterization of thin film electrodes toward developing a DNA transistor.
PubMed: Increase on the initial soluble heme levels in acidic conditions is an important mechanism for spontaneous heme crystallization in vitro.
PubMed: The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4-thiobutylamidine conjugate.
PubMed: Drug release from and sterilization of in situ cubic phase forming monoglyceride drug delivery systems.
PubMed: Development of an LC-MS/MS method for analysis of interconvertible Z/E isomers of the novel anticancer agent, Bp4eT.
PubMed: Purification, crystallization and preliminary X-ray analysis of bifunctional isocitrate dehydrogenase kinase/phosphatase in complex with its substrate, isocitrate dehydrogenase, from Escherichia coli.
PubMed: [Effects of seed priming on drought tolerence in Prunella vulgaris].
PubMed: Zn(II)-PEG 300 globules as soft template for the synthesis of hexagonal ZnO micronuts by the hydrothermal reaction method.
PubMed: Crystallization and preliminary X-ray analysis of FliJ, a cytoplasmic component of the flagellar type III protein-export apparatus from Salmonella sp.
PubMed: Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT.
PubMed: Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants.
PubMed: Development and evaluation of a chloramphenicol hypertonic ophthalmic solution.
PubMed: Formulation and evaluation of ondansetron nasal delivery systems.
PubMed: Prophylactic effect of gossypin against percutaneously administered sulfur mustard.
PubMed: Stable carbamazepine colloidal systems using the cosolvent technique.
PubMed: Crystallization and preliminary X-ray crystallographic analysis of the Escherichia coli outer membrane cobalamin transporter BtuB in complex with the carboxy-terminal domain of TonB.
PubMed: Crystallization of hepatocyte nuclear factor 1beta in complex with DNA.
PubMed: [Theophylline semi-solid matrices containing polyethyleneglycols. 3--Mechanism of release].
PubMed: Altered specificity of lactococcal proteinase p(i) (lactocepin I) in humectant systems reflecting the water activity and salt content of cheddar cheese.
PubMed: Preclinical pharmacology of the novel antitumor agent adaphostin, a tyrphostin analog that inhibits bcr/abl.
PubMed: Solubility of (+/-)-ibuprofen and S (+)-ibuprofen in the presence of cosolvents and cyclodextrins.
PubMed: HPLC study on stability of pyridoxal isonicotinoyl hydrazone.
PubMed: Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
PubMed: A flow injection analysis/mass spectrometry method for the quantification of polyethylene glycol 300 in drug formulations.
PubMed: Influence of formaldehyde impurity in polysorbate 80 and PEG-300 on the stability of a parenteral formulation of BMS-204352: identification and control of the degradation product.
PubMed: Solubilizing excipients in oral and injectable formulations.
PubMed: Pharmaceutical development and manufacturing of a parenteral formulation of a novel antitumor agent, VNP40101M.
PubMed: Multidrug resistance P-glycoprotein: crucial significance in drug disposition and interaction.
PubMed: Solubility of guaifenesin in the presence of common pharmaceutical additives.
PubMed: Tape stripping and sodium dodecyl sulfate treatment increase the molecular weight cutoff of polyethylene glycol penetration across murine skin.
PubMed: Development of indomethacin Carbopol ETD 2001 gels and the influence of storage time and temperature on their stability.
PubMed: In vivo protection by amifostine and DRDE-07 against sulphur mustard toxicity.
PubMed: NMR-based metabonomic studies on the biochemical effects of commonly used drug carrier vehicles in the rat.
PubMed: A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro.
PubMed: Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers.
PubMed: Size selectivity between gap junction channels composed of different connexins.
PubMed: Isolation of plasmid DNA from cell lysates by aqueous two-phase systems.
PubMed: Crystallographically oriented mesoporous WO3 films: synthesis, characterization, and applications.
PubMed: Prophylactic efficacy of amifostine and its analogues against sulphur mustard toxicity.
PubMed: Molecular weight dependence of polyethylene glycol penetration across acetone-disrupted permeability barrier.
PubMed: Intranasal bioavailability of buprenorphine in rabbit correlated to sheep and man.
PubMed: Effect of solubilizing excipients on permeation of poorly water-soluble compounds across Caco-2 cell monolayers.
PubMed: Intranasal absorption of buprenorphine--in vivo bioavailability study in sheep.
PubMed: Bioaffinity extraction of glucoamylase in aqueous two-phase systems using starch as free bioligand.
PubMed: Study of phase behavior of poly(ethylene glycol)-polysorbate 80 and poly(ethylene glycol)-polysorbate 80-water mixtures.
PubMed: Allergic contact dermatitis to polyethylene glycol and nitrofurazone.
PubMed: Bilayered biodegradable poly(ethylene glycol)/poly(butylene terephthalate) copolymer (Polyactive) as substrate for human fibroblasts and keratinocytes.
PubMed: Intranasal absorption of melatonin in vivo bioavailability study.
PubMed: Surfactant dissolution and water solubilization in chlorine-free liquified gas propellants.
PubMed: Aqueous two-phase partitioning sample preparation prior to liquid chromatography of hydrophilic drugs in blood.
PubMed: Separation and purification of glucoamylase in aqueous two-phase systems by a two-step extraction.
PubMed: Aqueous two-phase systems as an alternative process route for the fractionation of small inclusion bodies.
PubMed: Aqueous two-phase partition of complex protein feedstocks derived from brain tissue homogenates.
PubMed: Polyethylene glycol nephrotoxicity secondary to prolonged high-dose intravenous lorazepam.
PubMed: Functional role of follicular cells in the generation of osmolarity-dependent Cl- currents in Xenopus follicles.
PubMed: Mechanism of solvent-induced thermal stabilization of alpha-amylase from Bacillus amyloliquefaciens.
PubMed: Role of oxygen radicals and arachidonic acid metabolites in the reverse passive Arthus reaction and carrageenin paw oedema in the rat.
PubMed: Polyethylene glycol: its adverse gastric effects in rats.
PubMed: Extension growth of the water mold Achlya: interplay of turgor and wall strength.
PubMed: The influence of vitamin K3 treatment on the pharmacokinetics and metabolism of (+)-propranolol in the rat.
PubMed: Analysis of saxitoxin in urine by continuous-flow fast-atom bombardment mass spectrometry.
PubMed: Comparison of ion-exchange high-performance liquid chromatography columns for purification of Sendai virus integral membrane proteins.
PubMed: Natriuretic activity of amlodipine, diltiazem, and nitrendipine in saline-loaded anesthetized dogs.
PubMed: [Anti-cerebral edema properties of PEG 300 in triethyltin poisoning].
PubMed: Toluene-induced ototoxicity by subcutaneous administration.
PubMed: Inhibition of pentagastrin-stimulated gastric acid secretion by upper intestinal hyperosmolality in chronic gastric fistula rats.
PubMed: Immediate and delayed allergic contact reactions to polyethylene glycol.
PubMed: Factors affecting the permeability of skin. The relation between in vivo and in vitro observations.
PubMed: [Activity of carbohydratephosphate metabolism enzymes in liver slices after freezing and thawing].
PubMed: Decontamination procedures for skin exposed to phenolic substances.
Synonyms   Articles   Notes   Search   Top
Please share your Comments.
Email Address:
 
 
 
 
Top of Page Home
Copyright © 1980-2020 Perflavory ™ Disclaimer Privacy Policy